139 related articles for article (PubMed ID: 20719370)
1. Class III NSRH: oncological outcome in 170 cervical cancer patients.
Ditto A; Martinelli F; Hanozet F; Reato C; Solima E; Zanaboni F; Grijuela B; Carcangiu M; Haeusler E; Raspagliesi F
Gynecol Oncol; 2010 Nov; 119(2):192-7. PubMed ID: 20719370
[TBL] [Abstract][Full Text] [Related]
2. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
3. Class III nerve-sparing radical hysterectomy versus standard class III radical hysterectomy: an observational study.
Ditto A; Martinelli F; Mattana F; Reato C; Solima E; Carcangiu M; Haeusler E; Mariani L; Raspagliesi F
Ann Surg Oncol; 2011 Nov; 18(12):3469-78. PubMed ID: 21556949
[TBL] [Abstract][Full Text] [Related]
4. Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: surgical morbidity and oncological results.
Colombo PE; Bertrand MM; Gutowski M; Mourregot A; Fabbro M; Saint-Aubert B; Quenet F; Gourgou S; Kerr C; Rouanet P
Gynecol Oncol; 2009 Sep; 114(3):404-9. PubMed ID: 19555996
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
6. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study.
Landoni F; Maneo A; Cormio G; Perego P; Milani R; Caruso O; Mangioni C
Gynecol Oncol; 2001 Jan; 80(1):3-12. PubMed ID: 11136561
[TBL] [Abstract][Full Text] [Related]
7. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
[TBL] [Abstract][Full Text] [Related]
8. [Feasibility of unilateral or bilateral nerve-sparing radical hysterectomy in patients with cervical cancer and evaluation of the post-surgery recovery of the bladder and rectal function].
Zhu T; Yu AJ; Shou HF; Chen X; Zhu JQ; Yang ZY; Zhang P; Gao YL
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):53-7. PubMed ID: 21575466
[TBL] [Abstract][Full Text] [Related]
9. Class I versus class III radical hysterectomy in stage IB1-IIA cervical cancer. A prospective randomized study.
Landoni F; Maneo A; Zapardiel I; Zanagnolo V; Mangioni C
Eur J Surg Oncol; 2012 Mar; 38(3):203-9. PubMed ID: 22244909
[TBL] [Abstract][Full Text] [Related]
10. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
[TBL] [Abstract][Full Text] [Related]
11. Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in patients with Ib1 stage cervical cancer: analysis of surgical and oncological outcome.
Pellegrino A; Vizza E; Fruscio R; Villa A; Corrado G; Villa M; Dell'Anna T; Vitobello D
Eur J Surg Oncol; 2009 Jan; 35(1):98-103. PubMed ID: 18760562
[TBL] [Abstract][Full Text] [Related]
12. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
[TBL] [Abstract][Full Text] [Related]
14. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
Lowe MP; Chamberlain DH; Kamelle SA; Johnson PR; Tillmanns TD
Gynecol Oncol; 2009 May; 113(2):191-4. PubMed ID: 19249082
[TBL] [Abstract][Full Text] [Related]
15. [Wertheim-operation: 5-year survival of 501 consecutive patients with cervical cancer].
Papp Z; Csapó Z; Mayer A; Hupuczi P
Orv Hetil; 2006 Mar; 147(12):537-45. PubMed ID: 16696377
[TBL] [Abstract][Full Text] [Related]
16. [Nerve-sparing radical hysterectomy and radical hysterectomy: a retrospective study].
Ju XZ; Li ZT; Yang HJ; Wu XH
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):605-9. PubMed ID: 20003790
[TBL] [Abstract][Full Text] [Related]
17. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
18. A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer.
Steed H; Rosen B; Murphy J; Laframboise S; De Petrillo D; Covens A
Gynecol Oncol; 2004 Jun; 93(3):588-93. PubMed ID: 15196849
[TBL] [Abstract][Full Text] [Related]
19. [A prospective study on nerve-sparing radical hysterectomy in patients with cervical cancer].
Li B; Zhang R; Wu LY; Zhang GY; Li X; Yu GZ
Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):606-10. PubMed ID: 19087497
[TBL] [Abstract][Full Text] [Related]
20. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
